- Home
- VHC vs ATRA Comparison
VHC vs ATRA Comparison
Compare VHC & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- ATRA
- Stock Information
- Founded
- VHC 2005
- ATRA 2012
- Country
- VHC United States
- ATRA United States
- Employees
- VHC N/A
- ATRA N/A
- Industry
- VHC Multi-Sector Companies
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VHC Miscellaneous
- ATRA Health Care
- Exchange
- VHC Nasdaq
- ATRA Nasdaq
- Market Cap
- VHC 48.2M
- ATRA 51.1M
- IPO Year
- VHC 1999
- ATRA 2014
- Fundamental
- Price
- VHC $18.46
- ATRA $11.58
- Analyst Decision
- VHC
- ATRA Strong Buy
- Analyst Count
- VHC 0
- ATRA 4
- Target Price
- VHC N/A
- ATRA $20.00
- AVG Volume (30 Days)
- VHC 28.3K
- ATRA 60.7K
- Earning Date
- VHC 08-13-2025
- ATRA 08-11-2025
- Dividend Yield
- VHC N/A
- ATRA N/A
- EPS Growth
- VHC N/A
- ATRA N/A
- EPS
- VHC N/A
- ATRA N/A
- Revenue
- VHC $3,000.00
- ATRA $199,732,000.00
- Revenue This Year
- VHC N/A
- ATRA N/A
- Revenue Next Year
- VHC N/A
- ATRA N/A
- P/E Ratio
- VHC N/A
- ATRA N/A
- Revenue Growth
- VHC N/A
- ATRA 475.53
- 52 Week Low
- VHC $3.68
- ATRA $5.01
- 52 Week High
- VHC $21.53
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- VHC 66.57
- ATRA 66.87
- Support Level
- VHC $18.07
- ATRA $8.53
- Resistance Level
- VHC $21.53
- ATRA $13.46
- Average True Range (ATR)
- VHC 2.12
- ATRA 0.96
- MACD
- VHC 0.13
- ATRA 0.28
- Stochastic Oscillator
- VHC 68.90
- ATRA 62.65
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).